Baseline Ferritin and Body Composition as Correlates of Longitudinal Metabolic Changes During an Energy-Restricted Mediterranean-Style Intervention Across Three Overweight Phlogistic-Related Clinical Conditions
Authors:
- Begoña de CuevillasBCBegoña de Cuevillas
- Amanda Cuevas-SierraACAmanda Cuevas-Sierra
- Andrea Higuera-GómezAHAndrea Higuera-Gómez
- Victor Moreno-TorresVMVictor Moreno-Torres
- Susana Mellor-PitaSMSusana Mellor-Pita
- María Martínez-UrbistondoMMMaría Martínez-Urbistondo
- Raquel CastejónRCRaquel Castejón
- Daniel De Luis-RománDaniel De Luis-Román
- J. Alfredo MartínezJMJ. Alfredo Martínez
Open Access
- 17 September 2026
- Vol. 18 (18) , 3044
Abstract
Background/Objectives: Chronic inflammation accompanies obesity, but correlations of longitudinal changes during dietary follow-up remain unclear. We described inflammatory profiles and examined associations of baseline ferritin and body composition with changes during a 32-week energy-restricted Mediterranean-style intervention. Methods: This prospective cohort included 190 adults classified as healthy overweight (n = 49), long COVID with overweight (n = 108), or metabolic syndrome (MS) with overweight (n = 33); 61 healthy normal-weight participants without long COVID or metabolic syndrome contributed to baseline comparisons only. The program prescribed a 30% energy deficit using a Mediterranean-style food-exchange system. Anthropometric, biochemical, inflammatory, lifestyle, and hepatic markers were assessed. MANOVA and multivariable regression examined inflammatory profiles and ferritin-change correlates. Results: Participants with overweight/obesity had a less favorable metabolic and inflammatory profile than normal-weight participants. Baseline ferritin was 100.5 (53.5–178.5), 76.0 (34.0–137.0), and 149.5 (102.0–245.0) ng/mL in the healthy overweight, long-COVID, and MS groups, respectively (omnibus p < 0.001). Mean changes were 8.0 ± 36.4, 3.3 ± 32.6, and −22.0 ± 58.8 ng/mL, respectively (omnibus p = 0.039), with the MS group showing greater decreases. Sex and muscle mass were associated with the multivariate inflammatory profile (both p < 0.001). Clinical group, baseline ferritin, muscle-mass change, MEDAS change, and Fatty Liver Index change were associated with ferritin change, although explanatory performance was limited (adjusted R2 = 0.16). Conclusions: Baseline ferritin and body composition were correlates of heterogeneous inflammatory-metabolic profiles and ferritin changes. These hypothesis-generating associations do not establish causal or mechanistic effects and require controlled confirmation with comprehensive iron-status assessment.Keywords
Funding Information
- Community of Madrid (Y2020/BIO-6600)
- Instituto de Salud Carlos III (CP25/00072)
- Novogene Co., Ltd.
This publication has 53 references indexed in Scilit:
- The Mediterranean diet as a metabolic strategy for healthy aging and non-communicable disease preventionThe Journal of Nutritional Physiology, 2026
- What is the link between the dietary inflammatory index and the gut microbiome? A systematic reviewEuropean Journal of Nutrition, 2024
- Modulatory role of Faecalibacterium on insulin resistance and coagulation in patients with post-viral long haulers depending on adiposityiScience, 2024
- Metabolic syndrome: risk factors, diagnosis, pathogenesis, and management with natural approachesFood Chemistry Advances, 2023
- Effect of calorie restriction diet on levels of C reactive protein (CRP) in obesity: A systematic review and meta-analysis of randomized controlled trialsDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2022
- Inflammation and sarcopenia: A systematic review and meta-analysisMaturitas, 2017
- Serum ferritin is associated with non-alcoholic fatty liver disease and decreased Β-cell function in non-diabetic men and womenJournal of Diabetes and its Complications, 2014
- Validación en población catalana del cuestionario internacional de actividad físicaGaceta Sanitaria, 2013
- Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical ImplicationsHepatology, 2010
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001